Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-25

Cancer Immunology and Immunotherapy

Objective

Our objective is to develop therapeutic anti-cancer vaccines that provide a clinical benefit to 40% of the vaccinated patients. This threshold, if reached in the absence of serious toxicity, would qualify immunotherapy as an additional standard treatment for cancer. To reach this objective, our project comprises three major activities. A first part of the project consists in clinical trials of vaccination, to compare various vaccines such as peptides and RNA, with different types of immunological adjuvants, and dendritic cells. Safety and clinical efficacy will be the primary endpoints of these trials. A large effort will be devoted to monitoring the anti-vaccine T cell responses, as examining the correlation between immunological and clinical response s to the vaccines will be crucial to understand which factor(s) limit tumour regression.

A second part of the project, tightly connected to the clinical trials because it uses biological material from the vaccinated patients, consists in optimising tumour vaccines and combating immune evasion. Foreseeable mechanisms of tumour escape will be analysed and correlated with the clinical results. Improved modalities of vaccination will be tested, and new target antigens will be identified. All these results will help to design improved vaccines. Finally, considering the complexity of mechanisms that may lead to or prevent tumour regression in vaccinated patients, we propose to explore more fundamental aspects of the anti-tumour immune response. This includes the cross presentation of tumour antigens by dendritic cells, recruitment of cells of the innate immune system, involvement of suppressor T cells, and development of murine models of inducible tumours. If new concepts emerge from this work, they will also help t o design better vaccines.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

FP6-2004-LIFESCIHEALTH-5
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

IP - Integrated Project

Coordinator

DE DUVE INSTITUTE
EU contribution
No data
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (23)

My booklet 0 0